ストックスクリーナーアプリを入手
284.02
0.85%
2.34
アフターアワーズ：
283.49
-0.53
-0.19%
前日終値:
$281.68
開ける：
$285
24時間の取引高:
2.29M
Relative Volume:
0.70
時価総額：
$152.82B
収益：
$32.53B
当期純損益:
$4.23B
株価収益率:
36.37
EPS:
7.81
ネットキャッシュフロー:
$6.28B
1週間 パフォーマンス:
+2.23%
1か月 パフォーマンス:
+9.55%
6か月 パフォーマンス:
-14.77%
1年 パフォーマンス:
-9.71%
1日の値動き範囲:
$281.64
$285.69
1週間の範囲:
$273.50
$285.69
52週間の値動き範囲:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
AMGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
284.02 | 152.82B | 32.53B | 4.23B | 6.28B | 7.81 |
|
LLY
Lilly Eli Co
|
823.23 | 778.66B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
85.34 | 379.90B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
152.87 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
ABBV
Abbvie Inc
|
175.65 | 310.55B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
98.95 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-14 | ダウングレード | Truist | Buy → Hold |
| 2024-09-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-05-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-11-02 | アップグレード | Truist | Hold → Buy |
| 2023-10-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-17 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 再開されました | BofA Securities | Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-04-24 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 繰り返されました | Truist | Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Underperform |
| 2022-10-31 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-10-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-09 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-09 | 繰り返されました | Jefferies | Buy |
| 2022-02-09 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-09 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-09-23 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 開始されました | Daiwa Securities | Buy |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-10-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | アップグレード | Truist | Hold → Buy |
| 2020-10-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | ダウングレード | Truist | Buy → Hold |
| 2020-10-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 再開されました | Guggenheim | Neutral |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-03-30 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-01-31 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-17 | 再開されました | Morgan Stanley | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-11-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-05-23 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Amgen Inc (AMGN) 最新ニュース
Ibex Wealth Advisors Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Here's Why Amgen (AMGN) is a Strong Momentum Stock - Yahoo Finance
Amgen Inc. (NASDAQ:AMGN) Shares Sold by New England Research & Management Inc. - MarketBeat
Milestone Asset Management LLC Buys 2,685 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
AMGN: 3 Biotech Stocks Revolutionizing Healthcare - StockNews.com
Citigroup Has Lowered Expectations for Amgen (NASDAQ:AMGN) Stock Price - Defense World
Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress - Investing.com
Federal Court delists Regeneron patent, clearing path for Amgen biosimilar launch - Law360 Canada
Swedbank AB Buys 25,482 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Set to Report Q4 Earnings: Is a Beat in the Cards? - MSN
Forsta AP Fonden Sells 4,200 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Premenstrual Syndrome Treatment Market May See Big Move: Major - openPR
Here's Why Amgen (AMGN) is a Strong Value Stock - Yahoo Finance
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Foster Victor Wealth Advisors LLC - MarketBeat
Montrusco Bolton Investments Inc. Sells 375,906 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
BMO Capital Adjusts Price Target on Amgen to $346 From $362, Keeps Outperform Rating - Marketscreener.com
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Amgen and Celltrion settle biosimilars patent dispute - The Pharma Letter
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Twelve Points Wealth Management LLC - MarketBeat
Perigon Wealth Management LLC Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Blue Trust Inc. - MarketBeat
2,647 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Union Bancaire Privee UBP SA - MarketBeat
Amgen (AMGN) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Celltrion Settlement Puts Prolia And Xgeva Biosimilars On Ice – But Only Until June - News & Insights
Bensler LLC Sells 3,489 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Matrix Asset Advisors Inc. NY Has $24.25 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Price Target Cut to $295.00 by Analysts at Citigroup - MarketBeat
Analyst Expectations For Amgen's Future - Benzinga
BankPlus Wealth Management LLC Takes $475,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Citigroup Adjusts Price Target on Amgen to $295 From $310, Maintains Neutral Rating - Marketscreener.com
Lebenthal Global Advisors LLC Raises Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Foundations Investment Advisors LLC Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Biotech Giant Amgen Launches Media Review 07/22/2024 - MediaPost Communications
Drive Wealth Management LLC Invests $236,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) Expected to Announce Earnings on Tuesday - MarketBeat
This Is What Whales Are Betting On Amgen - Benzinga
Amgen Deal Blocks Celltrion's Bone-Drug Biosimilars Until June - Bloomberg Law
Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now? - MSN
Biological Drugs Strategic Research Report 2024-2030, Profiles of 45+ Players Including Abbott Laboratories, Amgen, Baxter, Biogen, BMS, Eli Lilly and Co, GSK, Merck, Novartis, and Pfizer - GlobeNewswire Inc.
Baldwin Wealth Partners LLC MA Sells 1,282 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Granite Group Advisors LLC Has $2.29 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stake Cut by Marshall Financial Group LLC - MarketBeat
Exchange Traded Concepts LLC Purchases 1,464 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen opens new drug substance facility in North Carolina, US - Yahoo Finance
Avior Wealth Management LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Blue Square Asset Management LLC Acquires 7,277 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Jamison Private Wealth Management Inc. Buys 997 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Alan B Lancz & Associates Inc. - MarketBeat
DGS Capital Management LLC Has $392,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by SG Americas Securities LLC - MarketBeat
Amgen Inc (AMGN) 財務データ
収益
当期純利益
現金流量
EPS
1.09%
大文字化:
|
ボリューム (24 時間):